Skip to main content
Charles Wendling Jr., MD, Oncology, Asheville, NC, Charles George Veterans Affairs Medical Center


Oncology Asheville, NC


Dr. Wendling is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Wendling's full profile

Already have an account?

Education & Training

  • Stanford Health Care
    Stanford Health CareFellowship, Blood & Bone Marrow Transplant, 2009 - 2010
  • Louisiana State University School of Medicine
    Louisiana State University School of MedicineFellowship, Hematology and Medical Oncology, 2006 - 2009
  • Creighton University School of Medicine (Omaha)
    Creighton University School of Medicine (Omaha)Residency, Internal Medicine, 1997 - 2000
  • LSU School of Medicine in Shreveport
    LSU School of Medicine in ShreveportClass of 1997

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2008 - Present
  • NC State Medical License
    NC State Medical License 2018 - 2024
  • LA State Medical License
    LA State Medical License 2005 - 2023
  • AR State Medical License
    AR State Medical License 2002 - 2006
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
  • Ray A. Barlow Scientific Symposium Research Finalist Louisiana State University Health Sciences Center/Feist Weiller Cancer Center, 2008

Clinical Trials

Publications & Presentations


  • Saftey of Total Therapy II with or without Thalidomide for Newly Diagnosed Myeloma: A study of 475 consecutive patients
    Anaissie, E., Jacobson, J., Fassas, A.,Zangari, M., Thertulien, R., Van Rhee, F., Talamo, G., Tricot, G., Wendling, C., Davis, C., Holmig, K., and Barlogie, B., Abstract#1675 Blood, Volume 102, Issue 11
  • Absence of Hypodiploidy and/or Chromosome 13 Abnormalities (hypo-CA 13) Confers Superior Survival in Multiple Myeloma Patients
    Fassas, A.,Sawyer, J., McCoy, J., Anaissie, E., Lee, C.K., Talamo, G., Wendling, C., Zangari, M., Van Rhee, F., Thertulien, R., Tricot, G., and Barlogie, B., Abstract #2534 Blood, Volume 102 Issue 11
  • Effect of dose of melphalan used in conditioning regimen on outcomes of autologous stem cell transplantation in overweight/obese patients with multiple myeloma.
    Elizabeth Ellent, Sachin Gopalkrishn Pai, Ashley Chasick, Qingyang Luo, Charles V. Wendling, Robert Emmons, Journal of Clinical Oncology, Ochsner Medical Center, New Orleans, LA, 2015
  • Join now to see all

Professional Memberships

Hospital Affiliations